Volume 12 Issue 4
Jul.  2021
Turn off MathJax
Article Contents
He Yu, Ou Zhiyu, Miao Yun. The latest progress on JC virus infection after renal transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(4): 484-488. doi: 10.3969/j.issn.1674-7445.2021.04.017
Citation: He Yu, Ou Zhiyu, Miao Yun. The latest progress on JC virus infection after renal transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(4): 484-488. doi: 10.3969/j.issn.1674-7445.2021.04.017

The latest progress on JC virus infection after renal transplantation

doi: 10.3969/j.issn.1674-7445.2021.04.017
More Information
  • Corresponding author: Miao Yun, Email: miaoyunecho@126.com
  • Received Date: 2021-04-19
    Available Online: 2021-07-13
  • Publish Date: 2021-07-15
  • JC virus (JCV) is a member of polyomaviridae family that infects approximately 70% of the population worldwide. JCV constantly stays in a latent state after the primary infection. In immunosuppressed individuals, especially under the circumstances of low cellular immune function, JCV may be reactivated and lead to severe clinical manifestations. In recent years, the correlation between JCV and complications after renal transplantation has captivated widespread attention. JCV-associated nephropathy (JCVAN) has been reported. Here, latest research progresses on the epidemiology, molecular biology, in vivo infection process, JCV and complications after renal transplantation, and the relationship between JCV and BKV were reviewed, aiming to provide reference for the adjustment of immunosuppressive regimen following renal transplantation.

     

  • loading
  • [1]
    TORRES C. Evolution and molecular epidemiology of polyomaviruses[J]. Infect Genet Evol, 2020, 79: 104150. DOI: 10.1016/j.meegid.2019.104150.
    [2]
    ATKINSON AL, ATWOOD WJ. Fifty years of JC polyomavirus: a brief overview and remaining questions[J]. Viruses, 2020, 12(9): 969. DOI: 10.3390/v12090969.
    [3]
    MAYBERRY CL, MAGINNIS MS. Taking the scenic route: polyomaviruses utilize multiple pathways to reach the same destination[J]. Viruses, 2020, 12(10): 1168. DOI: 10.3390/v12101168.
    [4]
    MAZZONI E, PELLEGRINELLI E, MAZZIOTTA C, et al. Mother-to-child transmission of oncogenic polyomaviruses BKPyV, JCPyV and SV40[J]. J Infect, 2020, 80(5): 563-570. DOI: 10.1016/j.jinf.2020.02.006.
    [5]
    FORNI D, CAGLIANI R, CLERICI M, et al. You will never walk alone: codispersal of JC polyomavirus with human populations[J]. Mol Biol Evol, 2020, 37(2): 442-454. DOI: 10.1093/molbev/msz227.
    [6]
    BERGER JR, DANAHER RJ, DOBBINS J, et al. Dynamic expression of JC virus in urine and its relationship to serostatus[J]. Mult Scler Relat Disord, 2020, 41: 101972. DOI: 10.1016/j.msard.2020.101972.
    [7]
    MAHLER C, SCHUMACHER AM, UNTERRAINER M, et al. TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy[J]. Brain, 2021, DOI: 10.1093/brain/awab127[Epub ahead of print].
    [8]
    SEPPÄLÄ HM, HELANTERÄ IT, LAINE PKS, et al. Archetype JC polyomavirus (JCPyV) prevails in a rare case of JCPyV nephropathy and in stable renal transplant recipients with JCPyV viruria[J]. J Infect Dis, 2017, 216(8): 981-989. DOI: 10.1093/infdis/jix435.
    [9]
    AGUILAR J, CHANG DH, LIN M, et al. JC virus-associated nephropathy in a post-heart and -kidney transplantation patient[J]. Transpl Infect Dis, 2020, 22(3): e13288. DOI: 10.1111/tid.13288.
    [10]
    WIEGLEY N, WALAVALKAR V, AUJLA H, et al. Clinicopathologic characteristics of JC virus nephropathy in kidney transplant recipients[J]. Transplantation, 2020, 105(5): 1069-1076. DOI: 10.1097/TP.0000000000003363.
    [11]
    QUERIDO S, FERNANDES I, WEIGERT A, et al. High-grade urothelial carcinoma in a kidney transplant recipient after JC virus nephropathy: the first evidence of JC virus as a potential oncovirus in bladder cancer[J]. Am J Transplant, 2020, 20(4): 1188-1191. DOI: 10.1111/ajt.15663.
    [12]
    ULERI E, PIU C, CAOCCI M, et al. Multiple signatures of the JC polyomavirus in paired normal and altered colorectal mucosa indicate a link with human colorectal cancer, but not with cancer progression[J]. Int J Mol Sci, 2019, 20(23): 5965. DOI: 10.3390/ijms20235965.
    [13]
    REOMA LB, TRINDADE CJ, MONACO MC, et al. Fatal encephalopathy with wild-type JC virus and ruxolitinib therapy[J]. Ann Neurol, 2019, 86(6): 878-884. DOI: 10.1002/ana.25608.
    [14]
    CIARDI MR, ZINGAROPOLI MA, IANNETTA M, et al. JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis[J]. Virol J, 2020, 17(1): 23. DOI: 10.1186/s12985-020-1295-5.
    [15]
    SIGNORINI L, DOLCI M, FAVI E, et al. Viral genomic characterization and replication pattern of human polyomaviruses in kidney transplant recipients[J]. Viruses, 2020, 12(11): 1280. DOI: 10.3390/v12111280.
    [16]
    LAUVER MD, LUKACHER AE. JCPyV VP1 mutations in progressive multifocalleukoencephalopathy: altering tropismor mediating immune evasion?[J]. Viruses, 2020, 12(10): 1156. DOI: 10.3390/v12101156.
    [17]
    SOLIS M, GUFFROY A, LERSY F, et al. Inadequate immune humoral response against JC virus in progressive multifocal leukoencephalopathy non-survivors[J]. Viruses, 2020, 12(12): 1380. DOI: 10.3390/v12121380.
    [18]
    SCHNEIDEWIND L, NEUMANN T, DRÄGER DL, et al. Leflunomide in the treatment of BK polyomavirus associated nephropathy in kidney transplanted patients -a systematic review[J]. Transplant Rev (Orlando), 2020, 34(4): 100565. DOI: 10.1016/j.trre.2020.100565.
    [19]
    LAUTENSCHLAGER I, JAHNUKAINEN T, KARDAS P, et al. A case of primary JC polyomavirus infection-associated nephropathy[J]. Am J Transplant, 2014, 14(12): 2887-2892. DOI: 10.1111/ajt.12945.
    [20]
    KANTARCI G, EREN Z, DEMIRAĞ A, et al. JC virus-associated nephropathy in a renal transplant recipient and comparative analysis of previous cases[J]. Transpl Infect Dis, 2011, 13(1): 89-92. DOI: 10.1111/j.1399-3062.2010.00567.x.
    [21]
    WEN MC, WANG CL, WANG M, et al. Association of JC virus with tubulointerstitial nephritis in a renal allograft recipient[J]. J Med Virol, 2004, 72(4): 675-678. DOI: 10.1002/jmv.20037.
    [22]
    FREEDMAN BI, KISTLER AL, SKEWES-COX P, et al. JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans[J]. Nephrol Dial Transplant, 2018, 33(11): 1960-1967. DOI: 10.1093/ndt/gfx368.
    [23]
    CHENG XS, BOHL DL, STORCH GA, et al. Inhibitory interactions between BK and JC virus among kidney transplant recipients[J]. J Am Soc Nephrol, 2011, 22(5): 825-831. DOI: 10.1681/ASN.2010080877.
    [24]
    RAY U, CINQUE P, GEREVINI S, et al. JC polyomavirus mutants escape antibody-mediated neutralization[J]. Sci Transl Med, 2015, 7(306): 306ra151. DOI: 10.1126/scitranslmed.aab1720.
    [25]
    BERZERO G, BASSO S, STOPPINI L, et al. Adoptive transfer of JC virus-specific T lymphocytes for the treatment of progressive multifocal leukoencephalopathy[J]. Ann Neurol, 2021, 89(4): 769-779. DOI: 10.1002/ana.26020.
    [26]
    HUSSAIN I, TASNEEM F, GILANI US, et al. Human BK and JC polyomaviruses: molecular insights and prevalence in Asia[J]. Virus Res, 2020, 278: 197860. DOI: 10.1016/j.virusres.2020.197860.
    [27]
    LIAW YC, CHEN CH, SHU KH, et al. Recombined sequences between the non-coding control regions of JC and BK viruses found in the urine of a renal transplantation patient[J]. Virus Genes, 2012, 45(3): 581-584. DOI: 10.1007/s11262-012-0815-9.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Article Metrics

    Article views (1154) PDF downloads(152) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return